[1]Wright M, Southcott E, MacLaughlin H, et al. Clinical practice guideline on undernutrition in chronic kidney disease. BMC Nephrol[J]. 2019, 20 (1): 370-380.[2]Cupisti A, Brunori G, Di Iorio BR, et al. Nutritional treatment of advanced CKD: twenty consensus statements. J Nephrol[J]. 2018, 31 (4): 457-473. [3]Kalantar-Zadeh K, Fouque D. Nutritional Management of Chronic Kidney Disease. N Engl J Med[J]. 2017, 377 (18): 1765-1776. [4]殷莺,龙泉,尤莉,等. 低蛋白配伍α酮酸饮食可直接影响肾损伤大鼠系膜细胞肾素-血管紧张素系统表达. 中华肾脏病杂志[J]. 2011, 27 (6): 435-441. [5]Gao X, Huang L, Grosjean F, et al. Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: a role for KLF15. Kidney Int[J]. 2011, 79 (9): 987-996. [6]Koppe L, Fouque D. The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD. Am J Kidney Dis[J]. 2019, 73 (2): 248-257.[7]Garneata L, Stancu A, Dragomir D, et al. Ketoanalogue-Supplemented Vegetarian Very Low-Protein Diet and CKD Progression. J Am Soc Nephrol[J]. 2016, 27 (7): 2164-2176. [8]Rhee CM, Ahmadi SF, Kovesdy CP, et al. Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials. J Cachexia Sarcopenia Muscle[J]. 2018, 9 (2): 235-245. [9]Mathew AT, Fishbane S, Obi Y, et al. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int[J]. 2016, 90 (2): 262-271. [10]Caria S, Cupisti A, Sau G, et al. The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol[J]. 2014, 15 (1): 172. [11]Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int[J]. 2013, 84 (6): 1096-1107. [12]林善锬、谌贻璞、钱家麒、等. 慢性肾脏病蛋白营养治疗共识. 实用糖尿病杂志[J]. 2005, 21 (5): 143-145. [13]WST557-2017. 慢性肾脏病患者膳食指导[S]. 中华人民共和国卫生行业标准. 中华人民共和国国家卫生和计划生育委员会, 2018[14]王嘉琳、袁伟杰、谷立杰、等. 糖尿病肾病大鼠骨骼肌蛋白能量消耗相关线粒体损伤及低蛋白联合α酮酸的作用. 中华肾脏病杂志[J]. 2013, 29 (11): 824-829[15]Parvanova A, Trillini M, Podesta MA, et al. Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial. Lancet Diabetes Endocrinol[J]. 2018, 6 (1): 27-40. [16]Luther JM. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol[J]. 2012, 23 (1): 10-12.[17]Mills KT, Chen J, Yang W, et al. Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease. JAMA[J]. 2016, 315 (20): 2200-2210. [18]Fouque D, Vennegoor M, ter Wee P, et al. EBPG guideline on nutrition. Nephrol Dial Transplant[J]. 2007, 22 Suppl (2): ii45-ii87. [19]Kovesdy CP, Appel LJ, Grams ME, et al. Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension. J Am Soc Hypertens[J]. 2017, 11 (12): 783-800. [20]Vervloet MG, Sezer S, Massy ZA, et al. The role of phosphate in kidney disease. Nature Reviews Nephrology[J]. 2016, 13 (1): 27-38. [21]Vervloet MG, van Ittersum FJ, Buttler RM, et al. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol[J]. 2011, 6 (2): 383-389. [22]Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol[J]. 2010, 5 (3): 519-530. [23]Chang AR, Miller ER, 3rd, Anderson CA, et al. Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial. Am J Kidney Dis[J]. 2017, 69 (2): 200-209. [24]Melamed ML, Chonchol M, Gutierrez OM, et al. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis[J]. 2018, 72 (6): 834-845. [25]Bushinsky DA. Clinical application of calcium modeling in patients with chronic kidney disease. Nephrol Dial Transplant[J]. 2012, 27 (1): 10-13. [26]de Boer IH, Zelnick LR, Ruzinski J, et al. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA[J]. 2019, 11 E1-E11. [27]de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet[J]. 2010, 376 (9752): 1543-1551. [28]Ikizler TA, Robinson-Cohen C, Ellis C, et al. Metabolic Effects of Diet and Exercise in Patients with Moderate to Severe CKD: A Randomized Clinical Trial. J Am Soc Nephrol[J]. 2018, 29 (1): 250-259. [29]Yokoyama Y, Nishimura K, Barnard ND, et al. Vegetarian diets and blood pressure: a meta-analysis. JAMA Intern Med[J]. 2014, 174 (4): 577-587. [30]Sumida K, Molnar MZ, Potukuchi PK, et al. Constipation and Incident CKD. J Am Soc Nephrol[J]. 2017, 28 (4): 1248-1258. [31]Gutierrez OM, Muntner P, Rizk DV, et al. Dietary patterns and risk of death and progression to ESRD in individuals with CKD: a cohort study. Am J Kidney Dis[J]. 2014, 64 (2): 204-213. [32]Chen X, Wei G, Jalili T, et al. The Associations of Plant Protein Intake With All-Cause Mortality in CKD. Am J Kidney Dis[J]. 2016, 67 (3): 423-430. [33]Qian Q. Metabolic Acidosis in a Patient with CKD. Clin J Am Soc Nephrol[J]. 2019, 14 (8): 1245-1247. [34]Goraya N, Simoni J, Jo C, et al. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int[J]. 2012, 81 (1): 86-93. [35]Meijers B, Evenepoel P, Anders HJ. Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol[J]. 2019, 15 (9): 531-545. [36]Rossi M, Johnson DW, Morrison M, et al. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. Clin J Am Soc Nephrol[J]. 2016, 11 (2): 223-231. [37]Soleimani A, Zarrati Mojarrad M, Bahmani F, et al. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int[J]. 2017, 91 (2): 435-442. [38]Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature[J]. 2018, 555 (7698): 623-628. [39]Poesen R, Windey K, Neven E, et al. The Influence of CKD on Colonic Microbial Metabolism. J Am Soc Nephrol[J]. 2016, 27 (5): 1389-1399. [40]Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol[J]. 2014, 25 (4): 657-670. [41]Milne AC, Potter J, Vivanti A, et al. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev[J]. 2009, (2): CD003288. [42]KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis[J]. 2007, 49 (2 Suppl 2): S12-154. [43]Ley SH, Hamdy O, Mohan V, et al. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet[J]. 2014, 383 (9933): 1999-2007. [44]Cano N, Fiaccadori E, Tesinsky P, et al. ESPEN Guidelines on Enteral Nutrition: Adult renal failure. Clin Nutr[J]. 2006, 25 (2): 295-310. [45]NICE. Renal replacement therapy and conservative management. National Institute for Health and Care Excellence: Clinical Guidelines. 2018[46]Garneata L, Mircescu G. Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. J Ren Nutr[J]. 2013, 23 (3): 210-213. [47]Brunori G, Viola BF, Parrinello G, et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis[J]. 2007, 49 (5): 569-580. [48]Moore LW, Byham-Gray LD, Scott Parrott J, et al. The mean dietary protein intake at different stages of chronic kidney disease is higher than current guidelines. Kidney Int[J]. 2013, 83 (4): 724-732. [49]He Y, Li Y, Yang X, et al. The dietary transition and its association with cardiometabolic mortality among Chinese adults, 1982-2012: a cross-sectional population-based study. Lancet Diabetes Endocrinol[J]. 2019, 7 (7): 540-548. |